Wells Fargo’s Telomir Pharmaceuticals TELO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $186 | Sell |
149
-10,122
| -99% | -$12.6K | ﹤0.01% | 5984 |
|
2025
Q1 | $33.2K | Buy |
10,271
+227
| +2% | +$733 | ﹤0.01% | 5074 |
|
2024
Q4 | $41.4K | Buy |
10,044
+8,245
| +458% | +$34K | ﹤0.01% | 5058 |
|
2024
Q3 | $11.6K | Buy |
1,799
+9
| +0.5% | +$58 | ﹤0.01% | 5358 |
|
2024
Q2 | $8.61K | Buy |
+1,790
| New | +$8.61K | ﹤0.01% | 5399 |
|